Invesco Ltd. Greenwich Life Sciences, Inc. Transaction History

Invesco Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$21.76 - $39.43 $3.22 Million - $5.84 Million	-148,087 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$38.65 - $46.11 $5.1 Million - $6.09 Million	-131,975 Reduced 47.12%	148,087 $5.79 Million
Q2 2021 Aug 17, 2021	BUY	$31.24 - $53.6 $8.75 Million - $15 Million	280,062 New	280,062 $12.6 Million

1.1M

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $158M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.